Navigation Links
Tute Genomics Raises $1.5M for Cloud-based Genome Analytics & Machine-learning for Gene Discovery
Date:12/31/2013

SALT LAKE CITY, Dec. 31, 2013 /PRNewswire-iReach/ -- Tute Genomics announced that it has raised $1.5 million in Seed Round funding to further develop its advanced genome analysis software, allowing researchers to rapidly discover novel disease genes & identify predictive biomarkers. Investors in this round include Wilmington Pharmatech, Salt Lake Life Sciences Angels, Peak Ventures, Park City Angel Network, and a number of individual angel investors. Tute Genomics participated in the BoomStartup accelerator program in Utah this year, and subsequently raised the most funds of any company in BoomStartup's history. Additionally, Tute raised approximately $300K from AngelList, via their new Syndicate mechanism.

(Photo: http://photos.prnewswire.com/prnh/20131231/MN39256)

"The cost of sequencing the human genome has dropped significantly in recent years, making it possible for whole genomes and exomes to be used in both clinical and research settings," says Reid J. Robison, MD MBA, a physician turned data-scientist and CEO of Tute Genomics. "However, data analysis remains as the major hurdle before widespread adoption and individualized medicine can become a reality." Tute's cloud-based genome interpretation platform is derived from the expertise underlying the ANNOVAR technology, one of the gold standards in genome annotation & interpretation. ANNOVAR, written by Tute Genomics President Dr. Kai Wang, has been cited by over 500 scientific publications, and has been used in more gene discovery studies than any other platform.  Building on this foundation, Tute now includes over 90 annotation types, scoring methods and genetic databases, and through an innovative cloud-computing pipeline, lets healthcare & research organizations interpret an entire human genome in less than 15 minutes, and a whole exome in less than 5 minutes. Tute also applies robust statistical models, allowing researchers to conduct large-scale case-control and family-based studies using whole genomes and exomes. Tute Genomics software uses proprietary machine-learning algorithms to rapidly prioritize clinically relevant genetic variants, genes and pathways resulting in improved performance of disease gene & biomarker discovery efforts.

Tute has over 100 registered users across a number of research and clinical institutions, including academic medical centers, CLIA labs and pharma/biotech companies, and has analyzed over 500 genomes since its launch in October 2013. With this successful round of funding, Tute Genomics is opening a new door for personalized medicine by enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment.

Media Contact: Lynn Dakoulas-Dobias, Tute Genomics, 801-710-4035, lynn@tutegenomics.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Tute Genomics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
2. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
3. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
4. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
5. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
6. First Plant Genomics Yield Technology Progresses
7. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
8. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
9. Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
10. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
11. Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... Phoenix, Arizona (PRWEB) , ... October 09, 2017 ... ... of Kindred, a four-tiered line of medical marijuana products targeting the needs of ... production and packaging of Kindred takes place in Phoenix, Arizona. , As operators ...
(Date:10/7/2017)... Arizona (PRWEB) , ... October ... ... 15 years’ experience providing advanced instruments and applications consulting for microscopy and ... in-house expertise in application consulting, Nanoscience Analytical offers a broad range of ...
(Date:10/7/2017)... 6, 2017  The 2017 Nobel Prize in ... Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to broaden ... biology community. The winners worked with systems manufactured ... produce highly resolved, three-dimensional images of protein structures ...
(Date:10/6/2017)... Washington, D.C. (PRWEB) , ... October 06, 2017 ... ... Cure) will host a lunch discussion and webinar on INSIGhT, the first-ever adaptive ... INSIGhT Principal Investigator, Dana-Farber Cancer Institute. The event is free and open to ...
Breaking Biology Technology:
(Date:8/23/2017)...  The general public,s help is being enlisted in what,s thought to ... and on the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest ... the gut. The project's goal is to help advance scientific knowledge of ... ...
(Date:6/14/2017)... -- IBM (NYSE: IBM ) is introducing several innovative partner ... developing collaboration between startups and global businesses, taking place in ... event, nine startups will showcase the solutions they have built ... France is one of ... 30 percent increase in the number of startups created between ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
Breaking Biology News(10 mins):